Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Andrean L Simons"'
Autor:
Wattawan Wongpattaraworakul, Allen Choi, Marisa R. Buchakjian, Emily A. Lanzel, Anand Rajan KD, Andrean L. Simons
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-21 (2024)
Abstract Background In oral squamous cell carcinoma (OSCC), the tumor-node-metastasis (TNM) staging system is a significant factor that influences prognosis and treatment decisions for OSCC patients. Unfortunately, TNM staging does not consistently p
Externí odkaz:
https://doaj.org/article/806d1d88e47e4d0ebd3042085d7dcdfa
Autor:
George J Weiner, Caitlin D Lemke-Miltner, Andrean L Simons, MM Hasibuzzaman, Briana Ibarra, Ishrat Khan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/9bb055443b834cd8af2c0910fb582951
Autor:
Wattawan Wongpattaraworakul, Katherine N. Gibson-Corley, Allen Choi, Marisa R. Buchakjian, Emily A. Lanzel, Anand Rajan KD, Andrean L. Simons
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundEpidermal growth factor receptor (EGFR) is well known as a general prognostic biomarker for head and neck tumors, however the specific prognostic value of EGFR in oral squamous cell carcinoma (OSCC) is controversial. Recently, the presence
Externí odkaz:
https://doaj.org/article/9c30253ab2b3436993c36caf59c7f333
Autor:
Yinwen Cheng, Nicholas Borcherding, Ayomide Ogunsakin, Caitlin D. Lemke-Miltner, Katherine N. Gibson-Corley, Anand Rajan, Allen B. Choi, Wattawan Wongpattaraworakul, Carlos H. F. Chan, Aliasger K. Salem, George J. Weiner, Andrean L. Simons
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract The Toll-like receptor 8 (TLR8) agonist VTX-2337 (motolimod) is an anti-cancer immunotherapeutic agent that is believed to augment natural killer (NK) and dendritic cell (DC) activity. The goal of this work is to examine the role of TLR8 exp
Externí odkaz:
https://doaj.org/article/d67bc1582e584855affb057717db487d
Autor:
Madelyn Espinosa-Cotton, Elana J. Fertig, Laura P. Stabile, Autumn Gaither-Davis, Julie E. Bauman, Sandra Schmitz, Katherine N. Gibson-Corley, Yinwen Cheng, Isaac J. Jensen, Vladimir P. Badovinac, Douglas Laux, Andrean L. Simons
Publikováno v:
Biomarker Research, Vol 7, Iss 1, Pp 1-11 (2019)
Abstract Background The epidermal growth factor receptor (EGFR) monoclonal IgG1 antibody cetuximab is approved for first-line treatment of recurrent and metastatic (R/M) HNSCC as a part of the standard of care EXTREME regimen (platinum/5-fluorouracil
Externí odkaz:
https://doaj.org/article/7cb94e7905894534bb5933db154e06cd
Autor:
Madelyn Espinosa-Cotton, Samuel N. Rodman III, Kathleen A. Ross, Isaac J. Jensen, Kenley Sangodeyi-Miller, Ayana J. McLaren, Rachel A. Dahl, Katherine N. Gibson-Corley, Adam T. Koch, Yang-Xin Fu, Vladimir P. Badovinac, Douglas Laux, Balaji Narasimhan, Andrean L. Simons
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-16 (2019)
Abstract Background Despite the high prevalence of epidermal growth factor receptor (EGFR) overexpression in head and neck squamous cell carcinomas (HNSCCs), incorporation of the EGFR inhibitor cetuximab into the clinical management of HNSCC has not
Externí odkaz:
https://doaj.org/article/506a541666684f3397618ae8f721a1c9
Autor:
Yinwen Cheng, Caitlin D Lemke-Miltner, Wattawan Wongpattaraworakul, Carlos H F Chan, Andrean L Simons
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background CMP-001 is a novel Toll-like receptor-9 agonist that consists of an unmethylated CpG-A motif-rich G10 oligodeoxynucleotide (ODN) encapsulated in virus-like particles. In situ vaccination of CMP-001 is believed to activate local tumor-assoc
Externí odkaz:
https://doaj.org/article/c3dc7d83db9b40159de5cdcb3819d943
Autor:
Andrean L. Simons, Apollina Goel, Adam T. Koch, Charlotte R. Feddersen, Arya Sobhakumari, Laurie Love-Homan, Elise V.M. Fletcher
Chronic inflammation plays a fundamental role in tumor promotion, migration, and invasion. With the use of microarray profiling, a profound increase was observed for those transcripts involved in proinflammatory signaling in epidermal growth factor r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::876fd26454ea29574000021cd963eb6b
https://doi.org/10.1158/1541-7786.c.6539634
https://doi.org/10.1158/1541-7786.c.6539634
Autor:
Andrean L. Simons, Apollina Goel, Adam T. Koch, Charlotte R. Feddersen, Arya Sobhakumari, Laurie Love-Homan, Elise V.M. Fletcher
PDF file - 77K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4afb2a6dc454ae6abae2fd7ee7c15a6b
https://doi.org/10.1158/1541-7786.22510470.v1
https://doi.org/10.1158/1541-7786.22510470.v1
Supplementary Figure Legend from EGFR Inhibition Induces Proinflammatory Cytokines via NOX4 in HNSCC
Autor:
Andrean L. Simons, Apollina Goel, Adam T. Koch, Charlotte R. Feddersen, Arya Sobhakumari, Laurie Love-Homan, Elise V.M. Fletcher
PDF file - 56K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ab3cc96122e32ed5c1ab206deea5d9
https://doi.org/10.1158/1541-7786.22510473
https://doi.org/10.1158/1541-7786.22510473